Madrigal Pharmaceuticals Appoints Mardi C. Dier as Chief Financial Officer
CONSHOHOCKEN, Pa., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel…
299,691$
7,94%
Echtzeit-Aktienkurs Madrigal Pharmaceuticals Corp.
Bid:
Ask: